Investor Overview

Why Interleukin Genetics?

1. Strong Patent Portfolio

   Stock Information
   ILIU - OTCQB Quote
   Annual Report
   SEC Filings

   
    
   The company has been granted twenty US patents, most of which focus on how variations in key inflammatory genes affect risk for important, common disorders such as heart disease and/or how knowledge of those variations could influence choice of prevention or therapy. In addition to its current US patent portfolio, the company has a large number of patents issued in other nations, as well as a substantial number in process.
    
2. Growing Consumer Interest in Using Genetic Information
    
   The Human Genome Project was completed about five years ago, setting the stage for a rapid increase in our ability to investigate the role of genes in risk for complex disorders such as osteoporosis and heart disease. The explosive growth of the internet, the obvious consumer demand for empowerment in health care decisions, and the rapid growth in understanding the role of genes in maintaining health is setting the stage for a new kind of genetic testing - the use of knowledge to prolong wellness. Beginning with its alliance with Alticor, a large consumer products company with a strong presence in nutrition, Interleukin is well positioned to be among the first to help consumers use genetic information as part of a healthy lifestyle.
    
3. Inflammation is a key component of many common late onset diseases
    
   Interleukin is highly focused on understanding genes that control inflammation, one of the body's key defense systems. Over the last decade it has become clear that inflammation plays a key role in heart disease, Alzheimer's disease, some cancers, osteoarthritis and, even, obesity. Our company is hard at work developing tests that will ask questions about inflammation and related genes and provide information that may help reduce the risk for or delay the onset of such disorders.

 

Transfer Agent	Corporate Counsel	General Information
U.S. Stock Transfer Corporation 1745 Gardena Avenue Suite 200 Glendale, CA 91204 Telephone: (818) 502-1404 Facsimile: (818) 502-0674 info@usstock.com	Mintz Levin Cohn Ferris Glovsky & Popeo, PC One Financial Center Boston, MA 02111 Telephone: (617) 542-6000 Facsimile: (617) 542-2241	Interleukin Genetics Incorporated 135 Beaver Street Waltham, MA 02452 Telephone: (781) 398-0700 Facsimile: (781) 398-0720 info@ilgenetics.com

back to top